GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » Repurchase of Stock

Hanmi Pharm Co (XKRX:128940) Repurchase of Stock : ₩-3,280 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co Repurchase of Stock?

Hanmi Pharm Co's Repurchase of Stock for the three months ended in Mar. 2025 was ₩0 Mil.

Hanmi Pharm Co's Repurchase of Stock for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-3,280 Mil.


Hanmi Pharm Co Repurchase of Stock Historical Data

The historical data trend for Hanmi Pharm Co's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Pharm Co Repurchase of Stock Chart

Hanmi Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,083.21 -4,873.54 -3,834.09 -3,070.61 -3,280.08

Hanmi Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,280.08 - - - -

Hanmi Pharm Co Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,280 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Pharm Co Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines